Merck & Co. has agreed to acquire Verona Pharma for $10 billion, the companies said, in a deal designed to expand the pharma ...

GREmLN leverages a graph-based architecture to represent gene-gene interactions to predict cell behavior for therapeutic ...

Pharmaceutical manufacturers are under immense pressure to streamline their processes, reduce waste, and improve output.

Findings suggest that Alzheimer’s risk genes drive tau buildup and spread through both network-based and independent mechanisms.